Learning platform for smoking cessation project: From begining to date

Although 35% of the adults in Turkey are current smokers, the number of trained physicians and smoking cessation (SC) clinics are not enough to meet the demand. Aim: This national project aimed to create the necessary infrastructure for providing SC therapy all-around the country and to train physicians in this topic. This project was run by Turkish Thoracic Society Tobacco Working Group and supported by a grant from Pfizer Foundation. Methods: For this purpose, an organization network including field training teams was planned. The training materials were prepared and standardized. A website of the project including a wide e-learning platform was created (www.sigarabirakmadaogrenmezemini.org). Results: Firstly, a central training program was planned. Forty volunteers from all regions of Turkey were participated to this program. Afterwards, field training programs were started to perform by these trainers. From the beginning field training sessions were performed in 11 cities with more than 300 participants. The project website was visited by 10.369 visitors and 518 participants completed e-training module since April 2011. Conclusion: The SÖZ project enabled a training ground that will last for years; a professional website and a trainer staff to generalize the program. Through this project, the integration of SC intervention in all health service steps will be provided, the number of SC clinics in Turkey will increase, and in future smoking rate will reduce in our country

Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature

<p>Abstract</p> <p>Background</p> <p>While tuberculosis of the breast is an extremely uncommon entity seen in western populations, it accounts for up to 3% of all treatable breast lesions in developing countries.</p> <p>Case presentations</p> <p>We reviewed three female cases of mammary tuberculosis that were diagnosed and treated in Turkey during the same calendar year. All three patients presented with a painful breast mass. In all cases, fine needle aspiration was nondiagnostic for mammary tuberculosis. However, the diagnosis of mammary tuberculosis was confirmed by histopathologic evaluation at the time of open surgical biopsy. All three patients were treated with antituberculous therapy for six months. At the end of the treatment period, each patient appeared to be clinically and radiologically without evidence of residual disease.</p> <p>Conclusion</p> <p>The diagnosis of mammary tuberculosis rests on the appropriate clinical suspicion and the histopathologic findings of the breast lesion. Its recognition and differentiation from that of a breast malignancy is absolutely necessary. Antituberculous chemotherapy, initiated immediately upon diagnosis, forms the mainstay of treatment for mammary tuberculosis.</p

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib

Ruxolitinib-associated acute respiratory distress has rarely been reported, mostly due to discontinuation of treatment. Herein we report a 58-year-old male patient with primary myelofibrosis who presented with malaise and dyspnea 15 days after initiation of the treatment. The patient was diagnosed as mild acute respiratory distress syndrome (ARDS). After excluding other potential causes such as infection and cardiac pathologies, it was considered secondary to ruxolitinib use. The medication was discontinued and 1 mg/kg methylprednisolone was given to prevent cytokine rebound syndrome and continuous positive airway pressure therapy was prescribed for ARDS. Symptomatic improvement and complete radiological resolution was observed. This case suggests that ARDS may develop secondary to ruxolitinib use and ARDS should be keep in mind in the cases with respiratory symptoms who were on treatment

Acute respiratory distress syndrome after the use of gadolinium contrast agent

Acute respiratory distress syndrome (ARDS) is a life-threatening medical emergency. The etiology of ARDS can involve various causes. ARDS associated with the use of iodinated contrast media is rarely reported, and the literature includes only one case of ARDS due to gadobutrol. A 46-year-old female patient presented to our emergency department with shortness of breath, wheezing, swelling of the lips, and difficulty swallowing about 30 minutes after undergoing magnetic resonance imaging with 6.5 ml (0.1 ml/kg) gadobutrol (Gadovist) contrast for a submandibular mass. She was treated for anaphylaxis, then immediately evaluated using chest x-ray and arterial blood gas analysis. Based on the findings, she was diagnosed with ARDS and started on continuous positive airway pressure (CPAP) ventilatory support and methylprednisolone at a dose of 1 mg/kg/day. On day 3 of follow-up, all symptoms had completely regressed. Keywords: ARDS, Contrast agent, Gadoliniu

The histopathologic examination of the specimen revealed granulomas with central caseation necrosis, epitheloid histiocytes, Langhans' giant cells, and intense lymphocytic infiltration at the periphery of the granulomas (H&E, ×40)

<p><b>Copyright information:</b></p><p>Taken from "Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature"</p><p>http://www.wjso.com/content/5/1/67</p><p>World Journal of Surgical Oncology 2007;5():67-67.</p><p>Published online 18 Jun 2007</p><p>PMCID:PMC1910599.</p><p></p

An ill-defined, hypoechoic, heterogenous 6 cm lesion is seen in the upper-inner quadrant of the left breast on ultrasonography

<p><b>Copyright information:</b></p><p>Taken from "Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature"</p><p>http://www.wjso.com/content/5/1/67</p><p>World Journal of Surgical Oncology 2007;5():67-67.</p><p>Published online 18 Jun 2007</p><p>PMCID:PMC1910599.</p><p></p

Mediolateral oblique mammographic views showing increased radioopacity within the upper pole of the left breast

<p><b>Copyright information:</b></p><p>Taken from "Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature"</p><p>http://www.wjso.com/content/5/1/67</p><p>World Journal of Surgical Oncology 2007;5():67-67.</p><p>Published online 18 Jun 2007</p><p>PMCID:PMC1910599.</p><p></p

Craniocaudad mammographic views showing generalized increased radioopacity within the left breast

<p><b>Copyright information:</b></p><p>Taken from "Mammary tuberculosis – importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature"</p><p>http://www.wjso.com/content/5/1/67</p><p>World Journal of Surgical Oncology 2007;5():67-67.</p><p>Published online 18 Jun 2007</p><p>PMCID:PMC1910599.</p><p></p